Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN Druckformat: 0893-9675
ISSN Online: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2018024855
pages 275-282

Epithelial-to-Mesenchymal Transition: Liaison between Cancer Metastasis and Drug Resistance

Feng Du
State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi 710032, China
Hao Liu
State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi 710032, China
Yuanyuan Lu
State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi 710032, China
Xiaodi Zhao
State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi 710032, China
Daiming Fan
State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi 710032, China

ABSTRAKT

Metastasis and drug resistance are two of the leading causes of death in cancer patients. Poor responses to antitumor drugs can lead to tumor cell dissemination and metastasis. On the other hand, cells that metastasize to lymph nodes and distant organs are liable to drug resistance. Recently, the epithelial–mesenchymal transition (EMT) has been found to play a critical role in cancer metastasis and drug resistance; however, the underlying and intrinsic links between them remain unclear. In this review, we summarize recent advances in tumor metastasis and drug resistance, and we focus especially on the association between EMT, metastasis, and drug resistance. We discuss the molecular mechanisms and potential pathways involved in the regulation of EMT, focusing simultaneously on the roles of EMT in modulating metastasis and drug resistance, especially the nature of their intrinsic links across different types of cancer.


Articles with similar content:

Linking Autophagy and the Dysregulated NFκB/ SNAIL/YY1/RKIP/PTEN Loop in Cancer: Therapeutic Implications
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 5-6
Benjamin Bonavida
Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 1
Carlos L. Arteaga, Brent N. Rexer
Targeting Integrins in Cancer
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 3-4
Chiara Pazzagli, Sandra Donnini
The Molecular and Cellular Biology of Pancreatic Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.8, 1998, issue 3-4
Theodore P. McDade, Frank J. Vittimberga, Jr. , Richard A. Perugini, Mark P. Callery
Anoikis and EMT: Lethal "Liaisons" during Cancer Progression
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Natasha Kyprianou, Zheng Cao, Theodore Livas